EDGEWELL PERSONAL CARE Co

Edgewell Personal Care reported a net loss of $(62.6)M for the nine months ended June 30, 2026, a significant decline from net earnings of $56.0M in the prior year, primarily due to losses from discontinued operations and impairment charges. Net sales for the nine-month period saw a modest increase of 1.36% to $1,512.4M. The company completed the divestiture of its Feminine Care segment for $340.0M, which included a $37.4M goodwill impairment charge, and continued with significant restructuring initiatives totaling $71.9M in charges. Despite the net loss, Edgewell increased cash and cash equivalents to $397.1M and reduced long-term debt by $138.3M.

Edgewell Personal Care Company announced its third fiscal quarter 2026 results, reporting net sales of $570.1 million, a 1.7% increase year-over-year, with organic net sales returning to growth at 1.1%. Adjusted diluted EPS remained flat at $0.72, exceeding expectations. The company's North America performance improved meaningfully, and the Board declared a quarterly cash dividend of $0.15 per common share. For the full fiscal year 2026, Edgewell narrowed its outlook for reported net sales, organic net sales, adjusted EPS, and adjusted EBITDA, though the mid-points for adjusted EPS and adjusted EBITDA remain unchanged.

Edgewell Personal Care Company announced a change in its Chief Supply Chain Officer position. Paul R. Hibbert will depart from the role effective June 1, 2026, and will be eligible for severance benefits. Concurrently, Anthony Freve will join the company as the new Chief Supply Chain Officer, with his appointment also effective June 1, 2026.

Edgewell Personal Care Company reported a net loss of $(10.6) million, or $(0.23) per share, for the three months ended March 31, 2026, a significant decline from net income of $29.0 million in the prior year. This period included the completion of the Feminine Care segment divestiture to Essity for approximately $340.0 million, which resulted in a $(14.6) million loss from discontinued operations and a $37.4 million goodwill impairment charge. The company also continued its restructuring initiatives, incurring $14.0 million in charges for the quarter.

Edgewell Personal Care Company announced second fiscal quarter 2026 results, reporting net sales of $519.5 million, a 0.6% increase, and Adjusted EPS of $0.60, with results exceeding expectations. The company reaffirmed its full-year outlook for organic net sales, Adjusted EPS, and Adjusted EBITDA. However, the full-year GAAP EPS outlook was lowered due to higher estimated restructuring and legal costs, with total restructuring charges now expected to be $90 million. The company also returned $22.9 million to shareholders through share repurchases and dividends.